Asthma knowledge and management practices of pharmacists in Greater Accra
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250604Keywords:
Asthma, Ghana, Knowledge, Management, PharmacistsAbstract
Background: Asthma continues to be a global public health problem, and community pharmacists are at the center of drug therapy in areas such as Greater Accra, Ghana.
Methods: This study determined what 177 community pharmacists knew about managing asthma and what barriers they faced in their practice. Data were collected using a structured questionnaire regarding demographics, asthma knowledge, daily management practices, and perceived barriers.
Results: Most pharmacists (55.93%) had a good understanding of asthma management, 42.37% had moderate knowledge, and 1.69% had poor knowledge, the results showed. More specific to asthma were pharmacists (100%), were well versed in asthma pathophysiology (100%), triggers (93.22%), and use of peak expiratory flow (PEF) meters (94.92%). However, some inconsistencies in practice were present. While inhalation techniques were assessed by 73.68%, treatment side effects were discussed by 79.31%; however, only 49.15% were routinely counselled on inhaled corticosteroids (ICS). In addition, only 18.64 percent ensured patients had written asthma action plans. Asthma Action Plans were lacking in 81.4%; there were inadequate training opportunities (64.4%); designated consultation areas were lacking (52.5%); pharmacists had insufficient time to care (52.5%) and had time constraints to care (55.9%). Our findings are consistent with global observations and highlight system-level challenges that impede effective asthma management.
Conclusions: Although the Greater Accra pharmacists are knowledgeable enough based on their low rates of noncompliance indicated by their blood pressure scores, we believe that gaps in their practices and barriers to narrowing these gaps must be bridged.
Metrics
References
Wutor VC, Atiemo M, Ayisi-Boateng NK, N’guessan BB. The evolutionary role of pharmacists in asthma management. Int J Curr Res. 2025;17(01):31484-90.
Aheto JMK, Udofia EA, Kallson E, Mensah G, Nadia M, Nirmala N, et al. Prevalence, socio-demographic and environmental determinants of asthma in 4621 Ghanaian adults: Evidence from Wave 2 of the World Health Organization’s study on global AGEing and adult health. PLoS One. 2020;15(12):e0243642. DOI: https://doi.org/10.1371/journal.pone.0243642
Urick BY, Meggs EV. Towards a greater professional standing: evolution of pharmacy practice and education, 1920-2020. Pharmacy. 2019;7(3):98. DOI: https://doi.org/10.3390/pharmacy7030098
Chidambaram Y, Vijayakumar V, Boopalan D, Arjunan A, Ravi P, Kuppusamy M. Immediate effect of fomentation on pulmonary function in a patient with bronchial asthma: a case series. TMR Integr Med. 2022;6:e22018. DOI: https://doi.org/10.53388/TMRIM202206018
Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204-22. DOI: https://doi.org/10.1016/S0140-6736(20)30925-9
Taqi A, Rowlands G, Rathbone AP. A systematic review and thematic synthesis to identify factors that influence pharmacists' involvement in asthma care services: An identity crisis. Explor Res Clin Soci Pharm. 2021;3:100051. DOI: https://doi.org/10.1016/j.rcsop.2021.100051
Padmavathy R, Geethu N, SajilaSylus S, Zacharia T. Assessment of knowledge, attitude, practice towards asthma and the impact of patient counselling on inhalation techniques in asthmatics. Int Res J Pharm. 2019;10(6):48-51. DOI: https://doi.org/10.7897/2230-8407.1006202
Mortimer K, Reddel HK, Pitrez PM, Bateman ED. Asthma management in low and middle-income countries: the case for change. Europ Respir J. 2022;60(3). DOI: https://doi.org/10.1183/13993003.03179-2021
Amin S, Soliman M, McIvor A, Cave A, Cabrera C. Understanding patient perspectives on medication adherence in asthma: a targeted review of qualitative studies. Patient Prefer Adher. 2020:541-51. DOI: https://doi.org/10.2147/PPA.S234651
Okoro RN, Nduaguba SO. Community pharmacists on the frontline in the chronic disease management: The need for primary healthcare policy reforms in low and middle-income countries. Explorat Res Clin Soc Pharm. 2021;2:100011. DOI: https://doi.org/10.1016/j.rcsop.2021.100011
Said AS, Hussain N, Kharaba Z, Al Haddad AH, Abdelaty LN, Hussein RR. Knowledge, attitude, and practice of pharmacists regarding asthma management: a cross-sectional study in Egypt. J Pharmac Pol Pract. 2022;15(1):35. DOI: https://doi.org/10.1186/s40545-022-00432-0
Boulet L-P, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O'Byrne PM. The global initiative for asthma (GINA): 25 years later. Europ Respir J. 2019;54(2). DOI: https://doi.org/10.1183/13993003.00598-2019
Koduah A, Asare BA, Gavor E, Gyansa-Lutterodt M, Andrews Annan E, Ofei FW. Use of evidence and negotiation in reviewing national standard treatment guidelines and essential medicines list: experience from Ghana. Health Policy and Planning. 2019;34(Supplement_2):ii104-ii20. DOI: https://doi.org/10.1093/heapol/czz107
Bridgeman MB, Wilken LA. Essential role of pharmacists in asthma care and management. J Pharm Pract. 2021;34(1):149-62. DOI: https://doi.org/10.1177/0897190020927274
Paoletti G, Keber E, Heffler E, Malipiero G, Baiardini I, Canonica GW, et al. Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma. Resp Medi. 2020;174:106199. DOI: https://doi.org/10.1016/j.rmed.2020.106199
Ndarukwa P, Chimbari MJ, Sibanda EN. Protocol on a systematic review of qualitative studies on asthma treatment challenges experienced in Sub-Saharan Africa. System Revi. 2019;8:1-6. DOI: https://doi.org/10.1186/s13643-019-1068-7
Akram W, Ijaz N, Butt MH, Ahmad A, Khalid W, Hamid H, et al. The extent of asthma knowledge among community pharmacists and its relationship with demographics and professional characteristics: a regional analysis. Lat Am J Pharm. 2020;39(5):862-8.
Kuipers E, Wensing M, Wong-Go E, Daemen BJ, De Smet PA, Teichert M. Adherence to guideline recommendations for asthma care in community pharmacies: actual and needed performance. NPJ Prim Care Respirat Medi. 2019;29(1):26. DOI: https://doi.org/10.1038/s41533-019-0139-5
Nguyen T-S, Nguyen TLH, Van Pham TT, Cao TBT, Hua S, Li SC. Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling–a simulated patient study. Respir Medic. 2018;144:50-60. DOI: https://doi.org/10.1016/j.rmed.2018.10.003
Lucas C, Williams K, Tudball J, Walpola RL. Community, hospital and industry preceptor perceptions of their role in experiential placements-the need for standardization of preceptor responsibilities and evaluations on students. Curr Pharm Teach Learn. 2018;10(11):1447-55. DOI: https://doi.org/10.1016/j.cptl.2018.08.002
Bullen K, Davison K, Hardisty J. Community pharmacy as an effective teaching and learning environment: Student perspectives from a UK MPharm programme. Curr Pharm Teach Learn. 2019;11(9):902-8. DOI: https://doi.org/10.1016/j.cptl.2019.05.007
Mes MA. Pharmacists as the delivery channel for adherence support in asthma: UCL (University College London); 2019.
Mohammed MA, Moles RJ, Chen TF. The impact of pharmaceutical care interventions on health-related quality-of-life outcomes is a systematic review and meta-analysis. Ann Pharmacother. 2016;50(10):862-81. DOI: https://doi.org/10.1177/1060028016656016
Hsu E, Bajaj T. Beta 2 agonists. StatPearls Publishing FL, USA; 2021.
Bollmeier SG, Prosser TR. Community pharmacy-based asthma services: current perspectives and future directions. Integr Pharm Res Pract. 2014;3:49-70. DOI: https://doi.org/10.2147/IPRP.S47331
Downloads
Published
How to Cite
Issue
Section
